We cordially invite you to the 4th Symposium of the BU Interdisciplinary Neuroscience Research Centre: From Clinical Applications to Neuro-Inspired Computation on Friday, the 16th of January 2026, 9:30-15:00 at the Lees Lecture Theatre (Talbot Campus, Poole House -outside).
The symposium consists of a journey from clinical case studies to new, emerging experimental and computational methodologies underpinning future translational applications. It is an opportunity for informal discussions on grant proposals and to explore shared interests with our external guests from the NHS and collaborating EU universities. The provisional schedule is:
9:30. Coffee.
9:50. Welcome Address and Keynote talk: Dr Mihalis Doumas, Queen’s University Belfast.
10.45-11:00. Coffee Break and Networking.
11:00-11:50. Session I. Clinical Neuroscience.
11.50 -12.50. Lunch and Grants Discussion.
12.50-13:45. Keynote talk: Dr Andre Rupp, University of Heidelberg.
13:45-14:00 Coffee Break and Networking.
14:00-14:50. Session II. Neuro-Inspired Computation.
14:50-15:00. Concluding Remarks and Invitation to become a member of the INRC network.
If you have any queries, please do not hesitate to contact Ellen Seiss, eseiss@bournemouth.ac.uk or Emili Balaguer-Ballester, eb-ballester@bournemouth.ac.uk.
Thank you very much, and we are looking forward to seeing you there.
Kind regards,
Ellen and Emili, on behalf of all of us.











BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
Portrait Concert featuring BU academic at L’Espace du Son Festival 2025, Brussels
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease